← Back to Dashboard

LAURUSLABS Laurus Labs Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare
₹ 1,394.30
+0.85%

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Covering
Price rose (+0.7%) on short-covering (OI down -0.8%), suggesting a temporary relief bounce rather than new buyers.

Analysis what the data is telling us about LAURUSLABS

In the last completed session, Laurus Labs Ltd. closed +0.65% with futures open interest moving -0.8%. That combination — price rising while OI shrinks — is classified as Short Covering. It typically reflects existing short sellers closing positions, not fresh buying. Short-covering rallies can be sharp but tend to fade without follow-through demand. The option PCR of 1.14 is balanced — no clear directional preference from option writers. Max-pain strike at ₹1,360 sits 2.5% below the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Laurus Labs Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Laurus Labs Ltd. points to a supportive setup at the next open.

F&O Positioning EOD derivatives setup

Buildup Class
Short Covering
bias: bullish
Futures OI
16,988,950
-139400 (-0.8%)
Option PCR (OI)
1.14
heavy put writing
Max Pain Strike
₹ 1,360
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,382.60
yesterday's EOD close
Index Contribution
not a Nifty 50 constituent
Traded Volume
1,443,846
live shares traded today
Upcoming Earnings
no report scheduled

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
89.3
price / earnings
P/B
14.2
price / book
ROE
17.7%
return on equity
Market Cap
₹ 75,290 Cr
total market value
Dividend Yield
0.17%
trailing yield
EPS (TTM)
₹ 15.62
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-06-30 · spot 1,394 · EOD 2026-06-03

Option writers expect range between 1,320 and 1,400+0.4% upside, -5.3% downside.
downside-skewed
Call OI (writers) Strike Put OI (writers)
12,750 +3k
IV 28% Δ 0.77 θ -0.8 ν 1
1330
88,400 -3k
IV 27% Δ -0.23 θ -0.5 ν 1
51,000 -3k
IV 23% Δ 0.77 θ -0.7 ν 1
1340
158,950 +5k
IV 26% Δ -0.26 θ -0.5 ν 1
636,650 +5k
IV 27% Δ 0.71 θ -0.8 ν 1
1350
365,500 +16k
IV 26% Δ -0.29 θ -0.6 ν 1
184,450 -21k
IV 27% Δ 0.67 θ -0.8 ν 1
1360 MP
324,700 +61k
IV 26% Δ -0.32 θ -0.6 ν 1
118,150 +0k
IV 27% Δ 0.63 θ -0.8 ν 1
1370
176,800 +6k
IV 25% Δ -0.36 θ -0.6 ν 1
183,600 +3k
IV 27% Δ 0.60 θ -0.9 ν 1
1380
280,500 +49k
IV 25% Δ -0.40 θ -0.6 ν 1
161,500 -10k
IV 26% Δ 0.56 θ -0.8 ν 2
1390
187,000 +32k
IV 25% Δ -0.44 θ -0.6 ν 2
788,800 -51k
IV 26% Δ 0.52 θ -0.8 ν 2
1400 R
418,200 +59k
IV 25% Δ -0.48 θ -0.6 ν 2
118,150 +15k
IV 26% Δ 0.48 θ -0.8 ν 2
1410
21,250 +10k
IV 24% Δ -0.53 θ -0.5 ν 2
199,750 +24k
IV 25% Δ 0.44 θ -0.8 ν 1
1420
37,400 +10k
IV 24% Δ -0.57 θ -0.5 ν 1
20,400 +20k
IV 25% Δ 0.40 θ -0.8 ν 1
1430
0
IV 163% Δ -0.43 θ -4.3 ν 1
0
IV 10% Δ 0.17 θ -0.2 ν 1
1440
6,800 +1k
IV 25% Δ -0.64 θ -0.5 ν 1
293,250 +18k
IV 25% Δ 0.32 θ -0.7 ν 1
1450
11,900 +3k
IV 24% Δ -0.69 θ -0.4 ν 1

Chain Interpretation

Spot Underlying 1,394.30
Key Resistance (R) 1,400
Key Support (S) 1,320
Max Pain Strike (MP) 1,360
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for LAURUSLABS options · 2026-06-30 expiry

Underlying: LAURUSLABS · Spot: ₹ 1,394.30 · Expiry: 2026-06-30 · Lot: 850

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others